Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dipsaci Radix is the dried root of *Dipsacus asper* Wall. ex DC. (synonym *Dipsacus asperoides* C.Y.Cheng & T.M.Ai), a plant in the Caprifoliaceae family. It is a staple of traditional Chinese and Korean medicine, where it is used to tonify the liver and kidneys, strengthen bones and tendons, and treat conditions such as osteoporosis, osteoarthritis, and bone fractures. The pharmacological profile of Dipsaci Radix is characterized by a high content of triterpenoid saponins (notably asperosaponin VI, also known as Akebia Saponin D), iridoids (such as sweroside and loganic acid), and phenolic acids. These constituents exert anti-inflammatory, anti-osteoporotic, and antithrombotic effects by modulating several key signaling pathways, including the NF-κB, MAPK, BMP-Smad, and Nrf2/HO-1 axes. Research indicates that it promotes osteoblastic differentiation and mineralization while inhibiting osteoclastogenesis and bone resorption.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dipsaci radix.